Why 63% of Medical Claim Denials Are Never Appealed (And What It's Costing You)

There is a number that should alarm every healthcare CFO and RCM director in the country: 63%. That is the percentage of denied medical claims that are never appealed, according to the American Hospital Association. In dollar terms, this translates to approximately $165 billion in recoverable revenue that practices and health systems simply leave on the table every year.

The broader denial problem is well-documented — denied claims cost the U.S. healthcare system over $262 billion annually. But the 63% statistic reveals a deeper failure: it is not just that claims are being denied, it is that providers have largely stopped fighting back. Understanding why teams do not appeal — and what it costs them — is the first step to building a system that actually recovers revenue.

The $262 Billion Problem in Context

To understand the scale of the opportunity, consider what denial rates look like across different payer types. Medicare Advantage plans deny approximately 6.2% of all prior authorization requests and an even higher percentage of post-service claims. Commercial payers average a 4.8% denial rate, while Medicaid hovers around 7.1%. Multiply those rates across the volume of claims a 100-physician group submits annually — roughly 180,000 to 250,000 claims — and you are looking at 9,000 to 17,500 denials per year.

At an average denial amount of $850 per claim, a 100-physician group is looking at $7.6M to $14.9M in denied revenue annually. If 63% of those denials go unchallenged — and the ones that are appealed win at a rate of roughly 84% when supported by documentation — the math becomes stark. That practice is leaving $4.8M to $9.4M per year in recoverable revenue uncollected.

Why Teams Stop Appealing: The Three Root Causes

1. Bandwidth: The Team Is Underwater

The most common reason denials go unappealed is simple: there are not enough hours in the day. A mid-sized RCM team handling 15,000 monthly claims might have two to three appeal specialists. Each formal appeal — gathering documentation, writing the letter, submitting through the payer portal — takes 45 minutes to two hours. At that throughput, a team can process 80 to 150 appeals per week. If 400 new denials arrive weekly, the math does not work. Teams triage by amount, work the high-dollar items, and let the rest age out.

2. Complexity: Not All Denials Are Worth Fighting

Not every denied claim is a winnable appeal. CARC code 50 (not medically necessary) requires clinical documentation to rebut. CARC code 29 (untimely filing) is almost never reversible. CARC code 97 (payment included in a previous adjudication) requires investigation into duplicate billing logic. Without a system to triage by recoverability, teams waste hours on denials they cannot win while letting recoverable claims expire.

3. Low Confidence: Teams Don't Know What Works

When an RCM specialist sits down to write an appeal letter, they face a blank page and an implicit question: what argument will actually move this payer? Without historical data on what clinical evidence resonates with Aetna versus United versus Blue Cross, appeal letters become generic. Generic appeal letters lose at a much higher rate — which teaches the team that appealing is not worth it. It is a self-reinforcing cycle of learned helplessness.

The Real Cost: A 100-Physician Practice Model

The 72% win rate in the "with NexaClaim" scenario is not hypothetical. When appeals are filed with the right clinical evidence, payer policy citations, and regulatory references — within timely filing windows — the win rate climbs dramatically. The difference between 58% and 72% is not luck; it is process.

5 Steps to Build a Winning Appeal Workflow

• Triage by recoverability, not just dollar amount. A $300 denial with CARC 16 (missing information) and a 95% win rate is worth more time than a $1,200 coverage denial with CARC 96 that has a 15% win rate. Score every denial before assigning.
• Establish timely filing calendars by payer. Most commercial payers give you 90–180 days from the denial date to appeal. Medicare gives 120 days for redeterminations. Missing these windows is an unforced error. Build automated alerts at 30, 14, and 7 days before deadline.
• Build a payer-specific evidence library. Track which clinical citations win with which payers. When CARC 50 denials from UnitedHealthcare have a 78% win rate when you cite the specific UHC coverage policy document, that data is gold. Maintain it.
• Automate first-level appeal letter generation. The first-level appeal letter for common denial categories (auth not obtained, untimely filing disputes, missing modifier corrections) can be 80–90% templated. Use AI to draft, humans to review and submit. This 5x multiplies team throughput.
• Track downstream outcomes and close the loop. The most important metric is not how many appeals you filed — it is how much revenue you recovered per analyst per month. Track this at the individual level, share it transparently, and use it to improve your triage and template library over time.

The Medicare Advantage Problem Requires Special Attention

Medicare Advantage plans deserve a separate callout because their denial behavior has become egregious. The Office of Inspector General found in 2022 that Medicare Advantage plans denied 13% of prior authorization requests that met Medicare coverage rules — and then reversed 75% of those denials when appealed. In 2026, with MA enrollment now exceeding 32 million beneficiaries, the volume of wrongful denials is enormous.

For Medicare Advantage denials, the appeal pathway has three levels: Organization Determination, Reconsideration, and then escalation to an Independent Review Entity (IRE). The key is knowing which level to target and how quickly. MA plans are required to issue expedited determinations within 72 hours when a standard timeline would seriously jeopardize the patient's health — but they frequently issue standard 30-day timelines on cases that qualify for expedited review. Challenging the timeline itself is often the first move.

The Bottom Line

The 63% statistic is not inevitable. It reflects a resource and process failure, not a fundamental limit on what is recoverable. Practices that build systematic appeal workflows — with AI-assisted triage, automated letter generation, payer-specific evidence libraries, and closed-loop outcome tracking — routinely achieve 80–90% appeal rates and 70%+ win rates.

The math is simple: a 100-physician group that increases its appeal rate from 37% to 85% and its win rate from 58% to 72% recovers an additional $4 million per year. At $10 per claim for a full AI-powered RCM platform, the annual cost is $2 million. The net return is $2 million — a 100% ROI just from denial management, before counting gains from improved coding accuracy and prior authorization automation.